SCHEMBL27743

SCHEMBL27743

C1CCC2CCC2C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2047082 1.00
SCHEMBL3767440 1.00 ALDH1A1 (0.89)
SCHEMBL18019251 1.00
SCHEMBL29759005 1.00 ALDH1A1 (0.89)
SCHEMBL19685101 1.00
SCHEMBL20193393 1.00 ALDH1A1 (0.89)
SCHEMBL18897676 1.00 ALDH1A1 (0.89)
SCHEMBL19072068 1.00 ALDH1A1 (0.89)
SCHEMBL21841873 1.00 ALDH1A1 (0.89)
SCHEMBL16878797 0.95 ALDH1A1 (0.80)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2176 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4228758-A1 SUBSTITUTED 6,7-DIHYDRO-5H-BENZO[7]ANNULENE COMPOUNDS AND THEIR DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF Sanofi (FR) 2023-08-23 EP claimed
WO-2022084280-A1 SUBSTITUTED 6,7-DIHYDRO-5H-BENZO[7]ANNULENE COMPOUNDS AND THEIR DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF SANOFI (FR) 2022-04-28 WO claimed
EP-3642264-A1 CURABLE SILICONE COMPOSITION AND APPLICATIONS AND USES THEREOF Momentive Performance Materials Inc. (US) 2020-04-29 EP claimed
US-10385210-B2 Curable silicone composition and applications and uses thereof MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2019-08-20 US claimed
US-10287400-B2 Curable silicone composition and applications and uses thereof MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2019-05-14 US claimed
EP-3443027-A1 CURABLE SILICONE COMPOSITION AND APPLICATIONS AND USES THEREOF Momentive Performance Materials Inc. (US) 2019-02-20 EP claimed
WO-2018236679-A1 CURABLE SILICONE COMPOSITION AND APPLICATIONS AND USES THEREOF MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2018-12-27 WO claimed
US-20180362764-A1 CURABLE SILICONE COMPOSITION AND APPLICATIONS AND USES THEREOF MOMENTIVE PERFORMANCE MATERIALS INC. 2018-12-20 US claimed
WO-2017180329-A1 CURABLE SILICONE COMPOSITION AND APPLICATIONS AND USES THEREOF MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2017-10-19 WO claimed
US-20170298188-A1 CURABLE SILICONE COMPOSITION AND APPLICATIONS AND USES THEREOF MOMENTIVE PERFORMANCE MATERIALS INC. 2017-10-19 US claimed
EP-2032535-B1 SPIROCYCLIC NITRILES AS PROTEASE INHIBITORS SANOFI SA (FR) 2012-08-01 EP claimed
US-20120015933-A1 Spirocyclic nitriles as protease inhibitors SANOFI-AVENTIS (FR) 2012-01-19 US claimed
EP-1657239-B1 Chromene compound TOKUYAMA CORP (JP) 2010-08-11 EP claimed
US-20090275523-A1 Spirocyclic nitriles as protease inhibitors SANOFI-AVENTIS (FR) 2009-11-05 US claimed
EP-2032535-A1 SPIROCYCLIC NITRILES AS PROTEASE INHIBITORS Sanofi-Aventis (FR) 2009-03-11 EP claimed
US-20080051598-A1 Process for Production of Polysubstituted Cyclobutanes and Polysubstituted Cyclobutenes NATIONAL UNIVERSITY CORPORATION TOHOKU UNIVERSITY (JP) 2008-02-28 US claimed
WO-2007137738-A1 SPIROCYCLIC NITRILES AS PROTEASE INHIBITORS SANOFI-AVENTIS (DE) 2007-12-06 WO claimed
EP-1775300-A1 PROCESS FOR PRODUCTION OF POLYSUBSTITUTED CYCLOBUTANES AND POLYSUBSTITUTED CYCLOBUTENES National University Corporation Tohoku Unversity (JP) 2007-04-18 EP claimed
US-5049497-A Novel process for the synthesis of the enantiomers of bicyclo(4.2.0)oct-2-en-7-one and derivatives SYNTEX (U.S.A.) INC. (US) 1991-09-17 US claimed
EP-0257610-A2 Process and intermediates for the synthesis of the enantiomers of bicyclo(4.2.0)oct-2-en-7-one and derivatives and for the synthesis of bicyclo(4.2.0)octane derivatives SYNTEX (U.S.A.) INC. (US) 1988-03-02 EP claimed